Addus HomeCare Co. (NASDAQ:ADUS) Receives Consensus Rating of “Moderate Buy” from Analysts

Addus HomeCare Co. (NASDAQ:ADUS) has been assigned an average rating of “Moderate Buy” from the nine ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $131.38.

ADUS has been the subject of a number of research analyst reports. TD Cowen upped their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Royal Bank of Canada restated an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Stephens reaffirmed an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a report on Tuesday, August 6th. Finally, KeyCorp started coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company.

Addus HomeCare Trading Down 0.2 %

Shares of NASDAQ ADUS opened at $129.10 on Friday. The company has a 50 day simple moving average of $130.61 and a two-hundred day simple moving average of $118.91. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $136.12. The stock has a market cap of $2.34 billion, a price-to-earnings ratio of 32.03, a PEG ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.94 EPS. Analysts forecast that Addus HomeCare will post 4.58 EPS for the current year.

Insider Activity at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the transaction, the director now owns 3,866 shares of the company’s stock, valued at $502,695.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

Several hedge funds have recently made changes to their positions in ADUS. Virtu Financial LLC acquired a new stake in shares of Addus HomeCare during the fourth quarter worth about $322,000. Wellington Management Group LLP raised its holdings in Addus HomeCare by 1.2% in the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after acquiring an additional 9,548 shares in the last quarter. Vanguard Group Inc. raised its holdings in Addus HomeCare by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after acquiring an additional 38,876 shares in the last quarter. GAMMA Investing LLC raised its holdings in Addus HomeCare by 40.8% in the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares in the last quarter. Finally, Bridge City Capital LLC raised its holdings in Addus HomeCare by 46.4% in the first quarter. Bridge City Capital LLC now owns 30,999 shares of the company’s stock valued at $3,203,000 after acquiring an additional 9,819 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.